Stockreport

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. [CNBC]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF The weekly injection is now cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, which refers to breathing interrupted during sleep due to [Read more]